Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study. Background: Rising serum cancer antigen 125 (CA-125) trends within ...
Efficacy of pegylated liposomal doxorubicin (PLD) and oxaliplatin (Ox) in pre-treated advanced epithelial ovarian cancer (EOC) in relation to BRCA status No significant financial relationships to ...
Recurrent epithelial ovarian carcinoma is considered an incurable disease, and second-line chemotherapy is mainly considered for palliation of symptoms and extension of survival. There are a growing ...
What Is a CA-125 Blood Test? Cancer antigen 125 (CA-125) is a protein found in ovarian cancer cells. A CA-125 blood test measures the amount of cancer antigen 125 in the bloodstream. The protein is ...
Current CA-125 thresholds may miss ovarian cancer in racially diverse patients, delaying treatment initiation and contributing to health disparities. Original CA-125 studies were conducted on ...
Cancer Antigen 125 (CA-125) testing shows 23% lower odds of elevated levels in American Indian and Black patients with ovarian cancer compared with White patients. Patients with false-negative CA-125 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results